Prospective study of pyodermabacteria and their in-vitro-antibiotic susceptibility;Prospektive erfassung wichtiger bakterieller erreger von pyodermien und deren in-vitro-antibiotikaempfindlichkeit

Hautarzt

Volumn 51, Issue 5, 2000, Pages 319-326

  Ochsendorf, Falk R ^a,b   Richter, Thorsten ^a   Niemczyk, U Martina ^a   Schäfer, Volker ^a   Brade, Volker ^a   Milbradt, Rainer ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Antibiotic therapy; Bacterial infections; Skin infections

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFACLOR; CEFADROXIL; CEFALEXIN; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DICLOXACILLIN; ERYTHROMYCIN; FLUCLOXACILLIN; FOSFOMYCIN; LEVOFLOXACIN; LINCOSAMIDE; METICILLIN; OFLOXACIN; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G; PENICILLIN V; PROPICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROXITHROMYCIN; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; HUMAN; LEG ULCER; MAJOR CLINICAL STUDY; NONHUMAN; PENICILLIN RESISTANCE; PSEUDOMONAS AERUGINOSA; PYODERMA; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A;

EID: 0034033862     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050051125     Document Type: Article

References (15)

1. Abeck D, Korting HC, Mempel M (1998) Pyodermien. Hautarzt 49:243-252
2. Boehncke WH, Zollner T (1999) Die Rolle bakterieller Superantigene in der Pathophysiologie der Haut. Hautarzt 50:91-97
3. Colsky AS, Kirsner RS, Kerdel FA (1998) Analysis of antibiotic susceptibilities of skin wound flora in hospitalized dermatology patients. The crisis of antibiotic resistance has come to the surface. Arch Dermatol 134:1006-1009
4. Espersen F (1998) Resistance to antibiotics used in dermatologcial practice. Br J Dermatol 139 (Suppl 53):4-8
5. Feldman P, Lynfield Y (1987) Antibiotic choice for pyodermas. J Am Acad Dermatol 17:859-860
6. Fish DG, Chow AT (1997) The clinical pharmacokinetics of levofloxacin. Clin Pharmacokinet 32:101-119
7. Höger PH (1998) Topische Antibiotika und Antiseptika: Agentien, Spektren, Nebenwirkungen. Hautarzt 49:331-347
8. Korting HC, Neubert U, Abeck D (1998) Current antimicrobial susceptibility of cutaneous bacteria to first line antibiotics. Int J Antimicrob Agents 10:165-168
9. Selwyn S (1963) Bacterial infections in a skin department. Br J Dermatol 75:26-28
10. Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, Huovinen P (1997) The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 337:441-446
11. Simon C, Stille W (1997). Antibiotika in Klinik und Praxis. Schattauer, Stuttgart New York
12. Steinmann D, Sebastian G, Wichmann G (1996) Rationale Antibiotikatherapie unter Berücksichtigung des bakteriologischen Keimspektrums und der Resistenzsituation in einer Klinik und Poliklinik für Hautkrankheiten. Akt Dermatol 22:292-296
13. Tebbe B, Wagner J, Orfanos CE (1995) Erregerspektrum von Hautinfektionen und Resistenzverhalten von Staphylococcus aureus und Pseudomonas aeruginosa. Z Hautkr 70:38-42
14. Vogel F, Stille W, Tauchnitz C (1996) Positions-papier zur Antibiotikatherapie in der Klinik. Chemotherapie Journal 1:23-27
15. Wistrom J, Lindholm C, Melhus A, Lundgren C, Hansson C (1999) Infections and treatment of chronic leg ulcers: the use of antibiotics is too excessive, restrictive prescription is recommended. Lakartidningen 96:42-46